Results 131 to 140 of about 4,060,629 (297)

Sequential action and beliefs under partially observable DSGE environments [PDF]

open access: yes, 2012
Revised and resubmitted at Computational EconomicsThis paper introduces a classification of DSGEs from a Markovian perspective, and positions the class of POMDP (Partially Observable Markov Decision Process) to the center of a generalization of linear ...
Kim, Seong-Hoon
core   +1 more source

Research of the Coupled Vibration Characteristic of Double Gearbox Transmission System

open access: yesJixie chuandong, 2018
Based on the generalized finite element method and the substructure method,a dynamics model of the double gearbox transmission system coupled by the diaphragm coupling is established.
Zhao Ying   +5 more
doaj  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Electro–dynamic Forces in Conductor of Spiral Shape

open access: yesИзвестия высших учебных заведений и энергетических объединенний СНГ: Энергетика, 2008
The paper contains vector-parametric equation of a spiral, expressions for calculation of the magnetic field induction established by an electrical conductor of a spiral shape, and also radial and tangential forces acting per unit of a conductor length ...
V. V. Pavlovets, A. S. Gerasimovich
doaj  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

History of the United States Army Forces, Central Canada.

open access: yes, 2010
The history of the United States Army Forces in Central Canada is presented here. The body of the history deals with the growth and establishment of the Headquarters of the Command in Winnipeg, Manitoba, Canada.
Headquarters, United States Armed Forces, Central Canada
core  

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Airborne command and center. Army Ground Forces study no. 25.

open access: yes, 2020
A history of the Airborne Command and Center was compiled by various hands during the course of the war. This was completely reworks by the author, Lt. Col. John T.
Historical Section, Army Ground Forces; Ellis, John T., Jr.
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy